Intensive insulin therapy for septic patients: A meta-analysis of randomized controlled trials.
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Background. Studies on the effect of intensive insulin therapy (IIT) in septic patients with hyperglycemia have given inconsistent results. The primary purpose of this meta-analysis was to evaluate whether it is effective in reducing mortality.Methods. We searched PubMed, Embase, the Cochrane Library, clinicaltrials.gov, and relevant reference lists up to September 2013 and including randomized controlled trials that compared IIT with conventional glucose management in septic patients. Study quality was assessed using the Cochrane Risk of Bias Tool. And our primary outcome measure was pooled in the random effects model.Results. We identified twelve randomized controlled trials involving 4100 patients. Meta-analysis showed that IIT did not reduce any of the outcomes: overall mortality (risk ratio [RR] = 0.98, 95% CI [0.85, 1.15],P=0.84), 28-day mortality (RR = 0.66, 95% CI [0.40, 1.10],P=0.11), 90-day mortality (RR = 1.10, 95% CI [0.97, 1.26],P=0.13), ICU mortality (RR = 0.94, 95% CI [0.77, 1.14],P=0.52), hospital mortality (RR = 0.98, 95% CI [0.86, 1.11],P=0.71), severity of illness, and length of ICU stay. Conversely, the incidence of hypoglycemia was markedly higher in the IIT (RR = 2.93, 95% CI [1.69, 5.06],P=0.0001).Conclusions. For patients with sepsis, IIT and conservative glucose management show similar efficacy, but ITT is associated with a higher incidence of hypoglycemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Forest plot with all-cause mortality showing no significant difference between IIT and control group (RR = 0.98, 95% CI [0.85, 1.15]). IIT: intensive insulin therapy. CI: confidence interval. M-H: Mantel-Haenszel.](https://figures.cochat.ai/paper-figures/3cdebbfc81a5441c977629a13f46cd68/intensive-insulin-therapy-for-septic-patients-a-meta-analysis-of-randomized-figure-2.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Meta-analyses also report a higher incidence of hypoglycemia (glucose < 40 mg/dL) in critically patients where blood glucose was targeted to 80–110 mg/dL [516, 517].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [517]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A recent patient-level mediation analysis suggested that a tidal volume that results in a driving pressure (plateau pressure minus set PEEP) below 12-15 cm H 2 O may be advantageous in patients without spontaneous breathing efforts (433).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [433]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Severe Sepsis and Septic Shock
Angus, D. C., & van der Poll, T. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208623 · Cited by 3,961
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., & Colette, C. (2006) · JAMA · doi:10.1001/jama.295.14.1681 · Cited by 2,444
Dungan, K. M., Braithwaite, S. S., & Preiser, J.-C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60553-5 · Cited by 1,431
McCowen, K. C., Malhotra, A., & Bistrian, B. R. (2001) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70154-8 · Cited by 1,170
Krinsley, J. S. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1471 · Cited by 1,165
Griesdale, D. E. G., de Souza, R. J., van Dam, R. M., Heyland, D. K., Cook, D. J., Malhotra, A., Dhaliwal, R., Henderson, W. R., Chittock, D. R., Finfer, S., et al. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.090206 · Cited by 1,096
Nationwide Trends of Severe Sepsis in the 21st Century (2000–2007)
Kumar, G., Kumar, N., Taneja, A., Kaleekal, T., Tarima, S., McGinley, E., Jimenez, E., Mohan, A., Khan, R. A., Whittle, J., et al. (2011) · Chest · doi:10.1378/chest.11-0352 · Cited by 615
Arabi, Y. M., Dabbagh, O. C., Tamim, H. M., Al-Shimemeri, A. A., Memish, Z. A., Haddad, S. H., Syed, S. J., Giridhar, H. R., Rishu, A. H., Al-Daker, M. O., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31818f21aa · Cited by 471 · cited 4×
“Through performing several sensitivity analyses (the trials with “low risk” of “random sequence generation” and “allocation concealment”, the trials with>500 patients, the trials with septic shock data, and studies with excluding unclear baseline characteristics) [17, 23, 24], the overall effect size was found to chan…”
BackgroundInfluentialGlucose variability and mortality in patients with sepsis*
Ali, N. A., OʼBrien, J. M., Dungan, K., Phillips, G., Marsh, C. B., Lemeshow, S., Connors, A. F., & Preiser, J.-C. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181810378 · Cited by 432
A comparison of statistical methods for combining event rates from clinical trials
Berlin, J. A., Laird, N. M., Sacks, H. S., & Chalmers, T. C. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080202 · Cited by 420
Management of Hyperglycemia in the Hospital Setting
Inzucchi, S. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp060094 · Cited by 391 · cited 1×
“Review Article Intensive Insulin Therapy for Septic Patients:”
BackgroundThe Search for Effective Therapy for Sepsis: Back to the Drawing Board?
Angus, D. C. (2011) · JAMA · doi:10.1001/jama.2011.1853 · Cited by 264
Intensive Insulin Therapy in Hospitalized Patients: A Systematic Review
Kansagara, D., Fu, R., Freeman, M., Wolf, F., & Helfand, M. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-4-201102150-00008 · Cited by 255
Benefits and Risks of Tight Glucose Control in Critically Ill Adults: A Meta-analysis
Wiener, R. S., Wiener, D. C., & Larson, R. J. (2008) · JAMA · doi:10.1001/jama.300.8.933 · Cited by 200
The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability
Waeschle, R. M., Moerer, O., Hilgers, R., Herrmann, P., Neumann, P., & Quintel, M. (2008) · Critical Care · doi:10.1186/cc7097 · Cited by 115
Blood glucose control in patients with severe sepsis and septic shock
Hirasawa, H., Oda, S., & Nakamura, M. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.4132 · Cited by 110
Stress-Induced Hyperglycemia in Patients With Severe Sepsis: A Compromising Factor for Survival
Λεωνίδου, Λ., Michalaki, M. A., Leonardou, A., Polyzogopoulou, E., Psirogiannis, A., Kyriazopoulou, V. E., Gogos, C. A., Fouka, K., Gerolymos, M. K., & Leonardos, P. (2008) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e318176abb4 · Cited by 80
Tight glycemic control may favor fibrinolysis in patients with sepsis*
Savioli, M., Cugno, M., Polli, F., Taccone, P., Bellani, G., Spanu, P., Pesenti, A., Iapichino, G., & Gattinoni, L. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819542da · Cited by 58
Tight glycemic control does not affect asymmetric-dimethylarginine in septic patients
Iapichino, G., Albicini, M., Umbrello, M., Sacconi, F., Fermo, I., Pavlovich, R., Paroni, R. C., Bellani, G., Mistraletti, G., Cugno, M., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-008-1158-9 · Cited by 50
Park, S., Kim, D.-G., Suh, G. Y., Kang, J. G., Ju, Y.-S., Lee, Y.-J., Park, J. Y., Lee, S. W., & Jung, K.-S. (2012) · Critical Care · doi:10.1186/cc11674 · Cited by 47
Dyslipidemia: a prospective controlled randomized trial of intensive glycemic control in sepsis
Cappi, S. B., Noritomi, D. T., Velasco, I. T., Curi, R., Alba‐Loureiro, T. C., & Soriano, F. G. (2012) · Intensive Care Medicine · doi:10.1007/s00134-011-2458-z · Cited by 46
McCulloh, R. J., Köster, M., & Chapin, K. C. (2013) · Virulence · doi:10.4161/viru.22788 · Cited by 44
Hyperglycemia in the Intensive Care Unit: No Longer Just a Marker of Illness Severity
Taylor, J. H., & Beilman, G. J. (2005) · Surgical Infections · doi:10.1089/sur.2005.6.233 · Cited by 37
Finfer, S. R. (2013) · Virulence · doi:10.4161/viru.25855 · Cited by 21
Blutzuckerkontrolle bei Patienten mit Sepsis und septischem Schock: Freund oder Feind?
Ellger, B., Westphal, M., Stubbe, H. D., van den Heuvel, I. A., Aken, H. V., & den Berghe, G. V. (2007) · Der Anaesthesist · doi:10.1007/s00101-007-1285-7 · Cited by 19
Yu, W., Li, W., Wang, X., Yan, X.-W., Qi, X.-P., Li, N., & Li, J. (2005) · PubMed · Cited by 18
Evaluation of Optimal Goal of Glucose Control in Critically III Patients
Xu, Y., He, W., 李彤, 周华, Chao, W., 高爽, & 许媛 (2008) · Zhonghua linchuang yingyang zazhi · doi:10.3881/j.issn.1008-5882.2008.04.003 · Cited by 10
Polli, F., Savioli, M., Cugno, M., Taccone, P., Bellani, G., Spanu, P., Pesenti, A. M., Iapichino, G., & Gattinoni, L. (2009) · PubMed · Cited by 7
[The influence of intensive insulin therapy on hemodynamics in patients with septic shock].
Dong, S., Qin, Y.-J., & Gao, Y. (2009) · PubMed · Cited by 3
Nutritional Support in Patients with Cardiovascular Diseases
肠外肠内营养学分会指南与规范编委会 (2008) · 中华临床营养杂志 · doi:10.3881/j.issn.1008-5882.2008.04.002 · Cited by 1
Research works printed but not linked: 8
- 2005, Zhonghua Wai Ke Za Zhi, 43, 29
- 2010, Journal of the American Medical Association, 303, 341
- 2009, Minerva Anestesiologica, 75, 417
- 2009, Intensive Care Medicine, 35
- 10.3760/cma.j.issn.1003-0603.2009.05.012 · doi:10.3760/cma.j.issn.1003-0603.2009.05.012
- 2013, Virulence, 4, 1
- 2012, Critical Care, 16
- 2013, The New England Journal of Medicine, 369, 840
Cited by
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
“The metaanalysis by Song et al (462) evaluated only septic patients and found that intensive insulin therapy did not change 28-day or 90-day mortality, but was associated with a higher incidence of hypoglycemia.”
MethodSurviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Metadata
- Authors
- Song, F., Zhong, L.-J., Han, L., Xie, G.-H., Xiao, C., Zhao, B., Hu, Y.-Q., Wang, S.-Y., Qin, C.-J., Zhang, Y., Lai, D.-M., Cui, P., & Fang, X.-M.
- Affiliations
- Zhejiang University (CN)
- First Affiliated Hospital Zhejiang University (CN)
- Department of Surgery, Children’s Hospital, School of Medicine, Zhejiang University, Zhuganxiang 57, Hangzhou 310003, China
- Department of Anesthesiology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Qingchun Road 79, Hangzhou 310003, China
- Venue
- BioMed Research International
- Publisher
- Hindawi Limited
- Published
- 2014
- Volume
- 2014
- Pages
- 1-10
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC4086473
- OpenAlex
- W2082857916
- Cited by
- 35
- References
- 38
- Citations by year
- 2025: 3 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 6 · 2019: 2 · 2018: 3 · 2017: 3 · 2016: 5 · 2015: 2
- FWCI
- 0.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- intensive insulin therapy, sepsis, septic shock, hyperglycemia, glucose management, mortality, hypoglycemia, intensive care unit, ICU length of stay, disease severity
- MeSH terms
- Humans, Hyperglycemia, Hypoglycemia, Insulin, Intensive Care Units, Randomized Controlled Trials as Topic, Treatment Outcome, PubMed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.